Middle East and Africa Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)
Market Introduction
The Middle East & Africa ocular drug delivery market includes the consolidated markets for UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa. The region occupies fourth position among the other region, the Saudi Arabia is the largest market in the Middle East & Africa region. The Saudi Arabia has made great strides in improving eye health. As per the WHO, around 8,000 children have functional low vision in Saudi Arabia. Congenital glaucoma is amongst the leading cause of childhood blindness in the country. Moreover, increasing use of computers and smartphones are creating demand for ocular pharmaceuticals during the forecast period. Prevention of blindness and deafness has been incorporated into Saudi Arabia’s new primary health care policy. To maintain a continuum of eye care, a 5-10-year programme that encompasses screening for Retinopathy of Prematurity (ROP), pre-school vision, diabetic retinopathy, glaucoma and cataract are being developed within existing health structures. The MOH is currently establishing four additional eye centres across the country to deliver these services. MOH has reactivated its Prevention of Blindness (PB) unit and moving operational responsibility to areas responsible for Public Health and non-communicable disease (NCDs). In 2013, approximately USD 2.66 million was allocated to blindness prevention specifically for diabetic retinopathy screening, the development of protocols for glaucoma, ROP and pre-school screening, and additional research.
The COVID-19 pandemic has become the most significant challenge in the region. Middle East countries have been registered a growth in the number of COVID cases. Many countries in the region have less developed and underfunded health systems. Apart from this, a huge population already face a growing burden of non-communicable diseases, making them more vulnerable to the virus. However, in view of the 'social distancing' requirements, many conferences across the globe have been cancelled or postponed. One of the largest ophthalmic conferences, the World Ophthalmic Congress, which was supposed to be held in Cape Town, South Africa has gone completely online with a virtual conference. These factors are expected to negatively impact the growth of the ocular drug delivery market in the region for short terms. However, as the vaccination progresses, and pandemic situation is under control the region will offer several growth prospects for the market player in ocular drug delivery market.
Get more information on this report :
Market Overview and Dynamics
The ocular drug delivery market in Middle East & Africa is expected to grow US$ 830.88 million by 2028 from US$ 1,272.46 million in 2021. The market is estimated to grow at a CAGR of 6.3% from 2021 to 2028. The incidence of eye diseases has increased significantly. In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, facilitating patients access to suitable medications and treatments for such conditions. Sightsavers is an international non-governmental organization—works in developing countries to treat and prevent eye diseases. A large population of India resides in rural areas, which has limited or no awareness about eye ailments. With its Rural Eye Health Programme, Sightsavers aims to create awareness, provide high-quality eye health services, and eradicate avoidable blindness in the rural population. Thus, the growing eye health awareness programs are likely to create growth opportunities for the market.
Key Market Segments
Middle East & Africa ocular drug delivery market is segmented based on technology, formulation type, disease type, end user. Based on technology, the implantable ocular drug delivery systems segment accounted for the highest share in 2021. Based on formulation type, the solution segment accounted for the highest share in 2021. Based on disease type, the cataract segment accounted for the highest share in 2021. Based on end user hospitals segment accounted for the highest share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on ocular drug delivery market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AbbVie Inc.; Bausch Health Companies Inc.; Novartis AG; Clearside Biomedical, Inc.; Alimera Sciences, Inc. among others.
Reasons to buy report
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa ocular drug delivery market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Middle East & Africa Ocular Drug Delivery Market Segmentation
Middle East & Africa Ocular Drug Delivery Market – By Technology
- Implantable Ocular Drug Delivery Systems
- Particulate Drug Delivery Systems
- Nano-Particle Drug Delivery System
- Others
Middle East & Africa Ocular Drug Delivery Market – By Formulation Type
- Solution
- Ointment
- Suspension
- Emulsion
- Liposomes and Nanoparticles
Middle East & Africa Ocular Drug Delivery Market – By Disease type
- Cataract
- Dry Eye Syndrome
- Macular Degeneration
- Glaucoma
- Diabetic Retinopathy
- Diabetic Macular Edema
- Others
Middle East & Africa Ocular Drug Delivery Market – By End User
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
Middle East & Africa Ocular Drug Delivery Market – By Country
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
Middle East & Africa Ocular Drug Delivery Market – Companies Mentioned
- AbbVie Inc.
- Bausch Health Companies Inc.
- Novartis AG
- Clearside Biomedical, Inc
- Alimera Sciences, Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Ocular Drug Delivery Market – By Technology
1.3.2 Middle East & Africa Ocular Drug Delivery Market – By Formulation Type
1.3.3 Middle East & Africa Ocular Drug Delivery Market – By Disease Type
1.3.4 Middle East & Africa Ocular Drug Delivery Market – By End User
1.3.5 Middle East & Africa Ocular Drug Delivery Market – By Country
2. Middle East & Africa Ocular Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Ocular Drug Delivery Market – Market Landscape
4.1 Overview
4.2 Expert Opinions
5. Middle East & Africa Ocular Drug Delivery Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Accelerated Research on Ocular Drug Delivery
5.2 Market Restraints
5.2.1 Side Effects Associated with Ocular Drug Delivery
5.3 Market Opportunities
5.3.1 Growing Awareness About Vision Care
5.4 Future Trends
5.4.1 Emergence of Innovative Products
5.5 Impact analysis
6. Middle East & Africa Ocular Drug Delivery – Market Analysis
6.1 Middle East & Africa Ocular Drug Delivery Market Revenue Forecast and Analysis
7. Middle East & Africa Ocular Drug Delivery Market Analysis – By Technology
7.1 Overview
7.2 Middle East & Africa Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)
7.3 Implantable Ocular Drug Delivery Systems
7.3.1 Overview
7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)
7.4 Particulate Drug Delivery Systems
7.4.1 Overview
7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)
7.5 Nano-Particle Drug Delivery System
7.5.1 Overview
7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Ocular Drug Delivery Market Analysis – By Formulation Type
8.1 Overview
8.1.1 Middle East & Africa Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)
8.2 Liposomes and Nanoparticles Market
8.2.1 Overview
8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
8.3 Solution
8.3.1 Overview
8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Emulsion
8.4.1 Overview
8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Suspension
8.5.1 Overview
8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Ointment
8.6.1 Overview
8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)
9. Middle East & Africa Ocular Drug Delivery Market Analysis – By Disease Type
9.1 Overview
9.2 Middle East & Africa Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)
9.3 Cataract
9.3.1 Overview
9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)
9.4 Dry Eye Syndrome
9.4.1 Overview
9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)
9.5 Macular Degeneration
9.5.1 Overview
9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)
9.6 Glaucoma
9.6.1 Overview
9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetic Retinopathy
9.7.1 Overview
9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)
9.8 Diabetic Macular Edema
9.8.1 Overview
9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Ocular Drug Delivery Market Analysis – By End User
10.1 Overview
10.2 Middle East & Africa Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
10.4 Ophthalmic Clinics
10.4.1 Overview
10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Ambulatory Surgical Centers
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
11. Middle East & Africa Ocular Drug Delivery Market – Country Analysis
11.1 Middle East & Africa Ocular Drug Delivery Market
11.1.1 Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
11.1.1.1 Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2 Saudi Arabia: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Saudi Arabia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Saudi Arabia: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2 UAE: Ocular Drug Delivery Market , by Technology – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 UAE: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 UAE: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 UAE: Ocular Drug Delivery Market , by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2 South Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 South Africa: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 South Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 South Africa: Ocular Drug Delivery Market, by End user– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.6 Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.7 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.8 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.9 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.10 Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User– Revenue and Forecast to 2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Middle East & Africa Ocular Drug Delivery Market
12.1 Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 AbbVie Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bausch Health Companies Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Alimera Sciences, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Novartis AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Clearside Biomedical, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Saudi Arabia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Saudi Arabia: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. UAE: Ocular Drug Delivery Market , by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. UAE: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. UAE: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. UAE: Ocular Drug Delivery Market , by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User– Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Ocular Drug Delivery Market
LIST OF FIGURES
Figure 1. Middle East & Africa Ocular Drug Delivery Market Segmentation
Figure 2. Middle East & Africa Ocular Drug Delivery Market Segmentation, By Country
Figure 3. Middle East & Africa Ocular Drug Delivery Market Overview
Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. Middle East & Africa Ocular Drug Delivery Market, Industry Landscape
Figure 7. Middle East & Africa PEST Analysis
Figure 8. Middle East & Africa Ocular Drug Delivery Market Impact Analysis of Driver and Restraints
Figure 9. Middle East & Africa Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2021- 2028
Figure 10. Middle East & Africa Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)
Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Middle East & Africa Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)
Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Middle East & Africa Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)
Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Middle East & Africa Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)
Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 33. Middle East & Africa: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (US$ Million)
Figure 34. Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
Figure 35. Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
- AbbVie Inc.
- Bausch Health Companies Inc.
- Novartis AG
- Clearside Biomedical, Inc
- Alimera Sciences, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa ocular drug delivery market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution